Wednesday, November 5, 2025
No Result
View All Result
The Financial Observer
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis
No Result
View All Result
The Financial Observer
No Result
View All Result
Home Business

‘Modern day snake-oil salesman’: The Liver Doc clashes with Bryan Johnson over ‘anti-ageing’ Blueprint

‘Modern day snake-oil salesman’: The Liver Doc clashes with Bryan Johnson over ‘anti-ageing’ Blueprint
Share on FacebookShare on Twitter


Bryan Johnson, an American entrepreneur, is famend for his anti-ageing programme referred to as Blueprint, which entails a plant-based food regimen, common train, and an in depth array of dietary supplements. 

Johnson claims his routine will reverse organic ageing and has led to biomarkers similar to these of an 18-year-old. Now, Dr Cyriac Abby Philips, a hepatologist from Kerala, has brazenly criticised Blueprint, drawing parallels between Johnson and notorious fraudsters like Elizabeth Holmes and Belle Gibson. 

Dr Philips, often called ‘The Liver Doc’, accuses Johnson of promoting overpriced and unverified dietary supplements. In keeping with Philips, Blueprint is a dangerous enterprise, devoid of considerable scientific backing. “It’s terrifying that folks don’t see Bryan Johnson as truly a well-evolved masculine type of fraudsters Elizabeth Holmes and Belle Gibson, promoting each costly and completely ineffective investigations and peddling probably harmful snake oil dietary supplements within the title of BLUEPRINT,” Dr Philips commented. 

In defence, Johnson insists his merchandise are reputable, stating all parts have “vitamins which have unbiased and sturdy scientific proof.” He additional claims they’re third-party examined, with publically out there certificates of study. 

“Blueprint provides further virgin olive oil, proteins, nuts, and vitamins which have unbiased and sturdy scientific proof. They’re third-party examined. The certificates of study are publically out there. They’re affordably priced,” Johnson asserted. 

Nonetheless, Dr Philips demanded scientific proof and dosage specifics, which he alleges Johnson has not supplied. 

The shortage of large-scale research on the security and interplay of drugs utilized in Blueprint raises further considerations, Dr Philips warns. He additionally flags potential unintended effects from the interplay of varied botanical extracts. 

Howdy @bryan_johnson, I’ve posted rational and logical questions relating to your BluePrint which I’ve gone by means of, and as scientific physician and a scientific researcher discovered it to be a rip-off.I do know precisely what I’m speaking about and do. I’m a Physician of Drugs. You might verify… https://t.co/T9h3jVnfOH

— TheLiverDoc (@theliverdr) March 31, 2025

Regardless of these points, Johnson contends his private well being enhancements are proof of Blueprint’s efficacy, although Dr Philips argues private anecdotes are usually not substitutes for scientific proof. 

Johnson, beforehand embroiled in disputes regarding office behaviour, has responded to Dr Philips’ critiques with questions concerning the physician’s motives, asking, “Cyriac why are you so indignant? Who harm you?” 

Nevertheless, Dr Philips stays resolute, regularly difficult Johnson to offer scientific validation for Blueprint’s claims. With out such proof, Philips suggests the programme stays speculative and probably deceptive for customers.  



Source link

Tags: anti-ageingantiageingBelle GibsonbiomarkersBlueprintbotanical extractsBryanBryan Johnsonclashesclinical evidenceconsumer safetydayDocDr Cyriac Abby PhilipsElizabeth HolmesJohnsonLiverModernpersonal healthplant-based dietsafety concernsSalesmanscientific evidencescientific validationscientific validitysnakeoilsupplementsThe Liver Doc
Previous Post

Barista FIRE at 36 with ONLY $500K by Trading “Stuff” for Substance

Next Post

Terminal 1 reopening revives Israel low-cost fare options

Related Posts

Politics And The Markets 11/05/25
Business

Politics And The Markets 11/05/25

November 5, 2025
Air India to resume Israel flights in January
Business

Air India to resume Israel flights in January

November 4, 2025
Look for better rates as lenders price to a lower prime rate
Business

Look for better rates as lenders price to a lower prime rate

November 3, 2025
India’s IPO boom signals market depth, but caution advised: Santosh Rao
Business

India’s IPO boom signals market depth, but caution advised: Santosh Rao

November 3, 2025
Transportation secretary says he doesn’t plan to fire air traffic controllers who don’t show up for work
Business

Transportation secretary says he doesn’t plan to fire air traffic controllers who don’t show up for work

November 2, 2025
Exxon Mobil Continues To Benefit From Advantaged Upstream (NYSE:XOM)
Business

Exxon Mobil Continues To Benefit From Advantaged Upstream (NYSE:XOM)

November 1, 2025
Next Post
Terminal 1 reopening revives Israel low-cost fare options

Terminal 1 reopening revives Israel low-cost fare options

Eurozone Inflation at 4-Month Low, DAX Rises as Rate Cut Bets Intensifies

Eurozone Inflation at 4-Month Low, DAX Rises as Rate Cut Bets Intensifies

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Trending
  • Comments
  • Latest
10 High Dividend Stocks Trading Near 52 Week Lows

10 High Dividend Stocks Trading Near 52 Week Lows

October 22, 2025
Robinhood Moves Into Mortgage Lending in Partnership With Sage Home Loans

Robinhood Moves Into Mortgage Lending in Partnership With Sage Home Loans

November 4, 2025
JetBlue Adds Perks for Families, Cuts for Entry-Level Elites

JetBlue Adds Perks for Families, Cuts for Entry-Level Elites

October 18, 2025
Landmark ruling in India treats XRP as property, not speculation

Landmark ruling in India treats XRP as property, not speculation

October 28, 2025
How is Farm ERP Market Transforming the Future of Digital Agriculture?

How is Farm ERP Market Transforming the Future of Digital Agriculture?

November 3, 2025
CyberRidge raises m to thwart post quantum threat

CyberRidge raises $26m to thwart post quantum threat

October 28, 2025
Technical Analysis of US Crude, XAUUSD and EURUSD for Today (November 5, 2025)

Technical Analysis of US Crude, XAUUSD and EURUSD for Today (November 5, 2025)

November 5, 2025
Politics And The Markets 11/05/25

Politics And The Markets 11/05/25

November 5, 2025
HeyMax Debuts in Hong Kong, Partnering with Cathay to Drive Regional Growth

HeyMax Debuts in Hong Kong, Partnering with Cathay to Drive Regional Growth

November 5, 2025
InnovAge Holding Corp. (INNV) Q1 2026 Earnings Call Transcript

InnovAge Holding Corp. (INNV) Q1 2026 Earnings Call Transcript

November 5, 2025
How Ripple built a blockchain bank without a banking license

How Ripple built a blockchain bank without a banking license

November 5, 2025
Palantir Valuation Defies Gravity as Growth, Politics, and FOMO Drive the Rally

Palantir Valuation Defies Gravity as Growth, Politics, and FOMO Drive the Rally

November 5, 2025
The Financial Observer

Get the latest financial news, expert analysis, and in-depth reports from The Financial Observer. Stay ahead in the world of finance with up-to-date trends, market insights, and more.

Categories

  • Business
  • Cryptocurrency
  • Economy
  • Fintech
  • Forex
  • Investing
  • Market Analysis
  • Markets
  • Personal Finance
  • Real Estate
  • Startups
  • Stock Market
  • Uncategorized

Latest Posts

  • Technical Analysis of US Crude, XAUUSD and EURUSD for Today (November 5, 2025)
  • Politics And The Markets 11/05/25
  • HeyMax Debuts in Hong Kong, Partnering with Cathay to Drive Regional Growth
  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2025 The Financial Observer.
The Financial Observer is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis

Copyright © 2025 The Financial Observer.
The Financial Observer is not responsible for the content of external sites.